STONERIDGE INVESTMENT PARTNERS LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1108831
RADNOR, PA
Position in ESPR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
18,237
-84.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 84%
Shared 16%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STONERIDGE INVESTMENT PARTNERS LLC holds $0 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
18,237 | $0 |
All Filings in ESPR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 18,237 | Shares | Sole | 2026-08-06 | |
| 2024-09-30 | — | 117,958 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | — | 117,958 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | — | 93,401 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | — | 29,256 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | — | 29,256 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | — | 29,256 | Shares | Sole | 2023-08-04 | |
| No filing history on record for this holder in this stock. | ||||||